Screening for lung cancer

Current Opinion in Oncology

Volumn 16, Issue 2, 2004, Pages 141-145

  Kawahara, Masaaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Early stage; Low dose computed tomography; Lung cancer; Overdiagnosis; Screening

Indexed keywords

AUTOMATION; BENIGN TUMOR; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY CANCER; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; PATIENT COUNSELING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING; TUMOR DIFFERENTIATION; UNITED STATES;

ADENOCARCINOMA; COIN LESION, PULMONARY; COST-BENEFIT ANALYSIS; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MASS SCREENING; RADIOGRAPHY, THORACIC; SMOKING; SPUTUM; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 1642528916     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200403000-00010     Document Type: Review

References (58)

1. Jemal A, Murray T, Samuels A, et al.: Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
2. Kubik AK, Parkin DM, Zatloukal P: Czech study on lung cancer screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 2000, 89:2363-2368.
3. Fontana RS, Sanderson DR, Miller WE, et al.: The Mayo Lung Project: preliminary report of "early cancer detection" phase. Cancer 1972, 30:1373-1382.
4. Melamed MR: Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000, 89:2356-2362.
5. Levin ML, Tockman MS, Frost JK, et al.: Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report. Recent Results Cancer Res 1982, 82:138-146.
6. Manser RL, Irving LB, Byrnes G, et al.: Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003, 58:784-789. First systematic review of lung cancer screening. More frequent screening (4-to 6-monthly) increased mortality from lung cancer.
7. Sagawa M, Saito Y, Sato M, et al.: The efficacy of sputum cytology in mass screening program for early detection of lung cancer. Anticancer Res 2003, 23:597-600.
8. Sagawa M, Nakayama T, Tsukada H, et al.: The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. Lung Cancer 2003, 41:29-36. Efficacy of mass screening for lung cancer is demonstrated by case-control study.
9. Nakayama T, Baba T, Suzuki T, et al.: An evaluation of chest X-ray screening for lung cancer in Gunma Prefecture, Japan: a population-based case-control study. Eur J Cancer 2002, 38:1380-1387.
10. Tsukada H, Kurita Y, Yokoyama A, et al.: An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study. Br J Cancer 2001, 85:1326-1331.
11. Sagawa M, Tsubono Y, Saito Y, et al.: A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer 2001, 92:588-594.
12. Nishii K, Ueoka H, Kiura K, et al.: A case-control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer 2001, 34:325-332.
13. Marcus PM: Conflicting evidence in lung cancer screening: randomized controlled trials versus case-control studies. Lung Cancer 2003, 41:37-39. This article is a good commentary on randomized controlled trials and case-controlled studies.
14. Gohagan JK, Prorok PC, Hayes RB, et al.: The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000, 21:251S-272S.
15. Henschke CI, McCauley DI, Yankelevitz DF, et al.: Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354:99-105.
16. Kaneko M, Eguchi K, Ohmatsu H, et al.: Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996, 201:798-802.
17. Sone S, Takashima S, Li F, et al.: Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351:1242-1245.
18. Miettinen OS, Yankelevitz DF, Henschke CI: Evaluation of screening for a cancer: annotated catechism of the gold standard creed. J Eval Clin Pract 2003, 9:145-150.
19. Swensen SJ, Jett JR, Hartman TE, et al.: Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003, 226:756-761. Description of the Mayo Clinic experience using low-dose CT.
20. Swensen SJ, Jett JR, Midthun DE, et al.: Computed tomographic screening for lung cancer: home run or foul ball? Mayo Clin Proc 2003, 78:1187-1188.
21. Sobue T, Moriyama N, Kaneko M, et al.: Screening for lung cancer with low-dose helical computed tomography: Anti-lung Cancer Association Project. J Clin Oncol 2002, 20:911-920.
22. Pastorino U, Bellomi M, Landoni C, et al.: Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003, 362:593-597. A study of the Milan group: low-dose spiral CT combined with selective use of PET can effectively detect early lung cancer.
23. van Klaveren RJ, de Koning HJ, Mulshine J, et al.: Lung cancer screening by spiral CT: what is the optimal target population for screening trials? Lung Cancer 2002, 38:243-252. Good criteria considering future treatment if lung cancer is detected.
24. Recruitment begins for lung cancer screening trial. J Natl Cancer Inst 2002, 94:1603.
25. Hirsch FR, Prindiville SA, Byers T, et al.: Sputum cytology as a marker of risk for lung cancer-preliminary results from the University of Colorado High Risk Cohort Study. Proc Am Soc Clin Oncol 2002, 21:301a.
26. McWilliams A, Mayo J, MacDonald S, et al.: Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003, 25:25.
27. Karabulut N, Toru M, Gelebek V, et al.: Comparison of low-dose and standard-dose helical CT in the evaluation of pulmonary nodules. Eur Radiol 2002, 12:2764-2769.
28. Li F, Sone S, Abe H, et al.: Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol 2003, 10:1013-1020.
29. Henschke CI, Yankelevitz DF, Mirtcheva R, et al.: CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178:1053-1057.
30. Armato SG 3rd, Altman MB, Wilkie J, et al.: Automated lung nodule classification following automated nodule detection on CT: a serial approach. Med Phys 2003, 30:1188-1197.
31. Armato SG 3rd, Li F, Giger ML, et al.: Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program. Radiology 2002, 225:685-692.
32. Aoyama M, Li Q, Katsuragawa S, et al.: Computerized scheme for determination of the likelihood measure of malignancy for pulmonary nodules on low-dose CT images. Med Phys 2003, 30:387-394.
33. Ford ME, Havstad SL, Flickinger L, et al.: Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence. Cancer Epidemiol Biomarkers Prev 2003, 12:28-33.
34. Black WC: Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000, 92:1280-1282.
35. Yankelevitz DF, Kostis WJ, Henschke CI, et al.: Overdiagnosis in chest radiographic screening for lung carcinoma: frequency. Cancer 2003, 97:1271-1275.
36. Marcus PM, Bergstralh FJ, Fagerstrom RM, et al.: Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000, 92:1308-1316.
37. Kashiwabara K, Koshi S, Itonaga K, et al.: Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 2003, 40:67-72.
38. Li F, Sone S, Abe H, et al.: Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology 2002, 225:673-683. Description of characteristics of lung cancer missed at CT screening in a general population, including nonsmokers and women.
39. Takashima S, Sone S, Li F, et al.: Small solitary pulmonary nodules (< or = 1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol 2003, 180:955-964.
40. Takashima S, Sone S, Li F, et al.: Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 2003, 180:1255-1263.
41. Ost D, Fein AM, Feinsilver SH: Clinical practice: the solitary pulmonary nodule. N Engl J Med 2003, 348:2535-2542.
42. Chirikos TN, Hazelton T, Tockman M, et al.: Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002, 121:1507-1514.
43. Wisnivesky JP, Mushlin AI, Sicherman N, et al.: The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 2003, 124:614-621.
44. Mahadevia PJ, Fleisher LA, Frick KD, et al.: Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 2003, 289:313-322. Good insight into the important factors influencing screening efficacy and the potential economic and safety consequences of screening programs.
45. Comber LA, Keith CJ, Griffiths M, et al.: Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET. Clin Radiol 2003, 58:706-711.
46. Banerjee AK, Rabbitts PH, George J: Lung cancer. 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities. Thorax 2003, 58:266-271. Review of fluorescence bronchoscopy.
47. Sutedja G: New techniques for early detection of lung cancer. Eur Respir J Suppl 2003, 39:57s-66s. Introduction of new techniques such as autofluorescence bronchoscopy and innovative sputum screening.
48. Schnoll RA, Miller SM, Unger M, et al.: Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development. Lung Cancer 2002, 37:257-265.
49. Schnoll RA, Bradley P, Miller SM, et al.: Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer 2003, 39:315-325.
50. Mulshine JL: Screening for lung cancer: in pursuit of pre-metastatic disease. Nat Rev Cancer 2003, 3:65-73. Introduction to more sensitive imaging tools for screening.
51. Bach PB, Niewoehner DE, Black WC: Screening for lung cancer: the guidelines. Chest 2003, 123:83S-88S. Guidelines for lung cancer screening.
52. Bach PB, Kelley MJ, Tate RC, et al.: Screening for lung cancer: a review of the current literature. Chest 2003, 123:723-823. Review of the current literature.
53. Gould MK, Sanders GD, Barnett PG, et al.: Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003, 138:724-735. The use of FDG-PET in relation to pretest probability of lung cancer and CT.
54. Baldwin J: New study questions marketing of spiral CT scanning to consumers. J Natl Cancer Inst 2003, 95:507-509. News about marketing of spiral CT scanning to consumers.
55. Berlin L: Liability of performing CT screening for coronary artery disease and lung cancer. AJR Am J Roentgenol 2002, 179:837-842. This report includes the radiologist's view.
56. Valle RP, Chavany C, Zhukov TA, et al.: New approaches for biomarker discovery in lung cancer. Expert Rev Mol Diagn 2003, 3:55-67. Review of biomarkers in lung cancer and introduction of antibiomix approach.
57. Bepler G, Goodridge Carney D, Djulbegovic B, et al.: A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 2003, 10:306-314. Many detailed tables are included in this review.
58. Swensen SJ: CT screening for lung cancer. AJR Am J Roentgenol 2002, 179:833-836. Perspective on CT screening.